The return of Wood's flagship Ark Innovation ETF lagged behind the S&P 500 for the five years through July 5.

A little competition can greatly benefit patients. Shareholders may have a more difficult path to navigate.

Ark Innovation has dropped 54% this year but has enjoyed inflow of $1.2 billion over the past six months.

Asset manager Cathie Wood also bought shares of her flagship fund's No. 3 holding and shares of a cryptocurrency exchange.

The list includes stocks that beat first-quarter-earnings estimates by more than 10% and garnered moats from Morningstar analysts.

Biotechs continue to decline like tech stocks but the sector is adequately capitalized, analysts say.

Biogen will stop developing a drug to treat a severe neurodegenerative disease, as it did not show sufficient benefit when tested in trials.

Jim Cramer says fund managers are looking for stocks that have been beaten down big, but still represent value.

Apple debuts latest Mac Book Pro; Zillow zapped as house purchases paused.

The builder confidence index breached the break-even measure of 50 in August for the first time since May 2020.

China is a crucial country for Tesla for its domination of the market of electric vehicles.